Content area

Abstract

Nestle performed the latest step in its acquisition financing dance with a deft EUR 850m 10 year bond that came at an extremely fine spread over mid-swaps, yet left investors wanting more. The Swiss foods group's $11.85bn agreed bid for Pfizer's baby food arm has led to a light flurry of bond issues since it was announced in April, but the company has kept investors - and its own banks - guessing as to how much debt it will raise and from what sources.

Full text

Turn on search term navigation

( (c) Euromoney Institutional Investor PLC Sept 2012)